BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 5:13:00 PM | Browse: 1388 | Download: 1238
Publication Name World Journal of Gastroenterology
Manuscript ID 5598
Country Japan
Received
2013-09-17 14:43
Peer-Review Started
2013-09-17 19:09
To Make the First Decision
2013-10-22 16:08
Return for Revision
2013-10-28 12:02
Revised
2013-11-15 17:20
Second Decision
2014-01-06 17:30
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2014-01-06 19:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-01-16 10:05
Publish the Manuscript Online
2014-01-26 20:08
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Topic Highlights
Article Title Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer
Manuscript Source Invited Manuscript
All Author List Takao Hiraki, Hideo Gobara, Toshihiro Iguchi, Hiroyasu Fujiwara, Yusuke Matsui and Susumu Kanazawa
Funding Agency and Grant Number
Corresponding Author Takao Hiraki, MD, Department of Radiology, Okayama University Medical School, 2-5-1 Shikatacho, Okayama 700-8558, Japan. takaoh@tc4.so-net.ne.jp
Key Words Radiofrequency ablation; Pulmonary metastases; Colorectal cancer; Ablation therapy; Lung
Core Tip Radiofrequency ablation (RFA) for pulmonary metastasis of colorectal cancer is technically simple. The procedure rarely results in death. The most common complication is pneumothorax, which occurs in up to 50% of patients. Severe complications are rare. Local progression after RFA is not rare and occurs in 10% or more of cases. The short- to mid-term survival after RFA appears promising and is approximately 85%-95% at 1 year and 45%-55% at 3 years. Long-term survival data are sparse. Better survival may be expected for patients with small metastasis, low carcinoembryonic antigen levels, and/or no extrapulmonary metastasis.
Publish Date 2014-01-26 20:08
Citation Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S. Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer. World J Gastroenterol 2014; 20(4): 988-996
URL http://www.wjgnet.com/1007-9327/full/v20/i4/988.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i4.988
Full Article (PDF) WJG-20-988.pdf
Full Article (Word) WJG-20-988.doc
Manuscript File 5598-Review.doc
Answering Reviewers 5598-Answering reviewers.pdf
Copyright License Agreement 5598-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5598-Language certificate.pdf
Peer-review Report 5598-Peer reviewer(s).pdf
Scientific Editor Work List 5598-Scientific editor work list.doc